bopindolol czechoslovak experi new beta blocker treatment hypertens bopindolol nonselect beta blocker mild intrins sympathomimet activ drug main benefit prolong effect hour possibl bopindolol singl daili dose fact patient adher double-blind studi center bopindolol metoprolol hypertens patient baselin diastol blood pressur BP mm Hg effect bopindolol metoprolol BP heart rate similar return normal valu patient drug studi center bopindolol level total cholesterol low-dens high-dens lipoprotein cholesterol triglycerid studi decreas total cholesterol apolipoprotein apo apo apo a/b ratio atherosclerot index deterior glucos toler immunoreact insulin respons month bopindolol administr bopindolol BP isometr isoton load BP fluctuat physic activ hypertens patient drug effect renal liver function electrolyt balanc hematolog paramet bopindolol use drug first choic mild moder hypertens bopindolol main advantag prolong action good toler benefici effect risk factor atherosclerosi lipid carbohydr metabol 